77
views
0
recommends
+1 Recommend
1 collections
    0
    shares
      scite_
      0
      0
      0
      0
      Smart Citations
      0
      0
      0
      0
      Citing PublicationsSupportingMentioningContrasting
      View Citations

      See how this article has been cited at scite.ai

      scite shows how a scientific paper has been cited by providing the context of the citation, a classification describing whether it supports, mentions, or contrasts the cited claim, and a label indicating in which section the citation was made.

       
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Case report of a pulmonary embolism in a patient with inferior vena cava compression by an 11 × 28 cm abdominal benign tumor

      Published
      case-report
      Bookmark

            Abstract

            Background:

            Pulmonary embolism (PE) is a life-threatening condition causing an abrupt reduction in blood flow in the pulmonary vasculature due to a migrating thrombus. The most cases are related to thromboembolism events originating in the lower limbs. However alternate etiologies should be suspected in certain clinical cases mainly in young patients with no risk factors.

            Case Presentation:

            We present a case of a young patient with proximal PE caused by compression on the inferior vena cava by an abdominal benign tumor measuring 11 × 28 cm. The patient was treated surgically and started on a therapeutic dose of Anticoagulation. The etiology of PE in this case was attributed to large vein compression promoting blood stasis and leading to thrombus formation.

            Conclusion:

            In short, acute PE in young female patients, is unusual and should raise suspicion for miscellaneous causes including vascular compression by tumors.

            Main article text

            Background

            The occurrence of pulmonary embolism (PE), especially in young individuals, should always raise the suspicion of an underlying cause [1]. In these patients, we need to rule out a state of hypercoagulable state in the absence of other reversible causes such as trauma, surgeries, and long periods of immobilization [1]. These causes include alteration and mutation in the coagulation pathway such as the factor V leiden mutation, antithrombin III deficiency, prothrombin gene mutation, and protein C and S deficiency [2]. Other causes of hypercoagulable states include tumors which are diagnosed by imaging and by measuring the tumor markers in the blood [3,4]. In an important number of patients with unprovoked PE, we find underlying malignancies [5]. A less common cause of PE is a stasis of blood in the venous system which may be due to an external compression of a vein by a structure such as a tumor [6]. Blood stasis will promote a state of hypercoagulability and thrombus formation with a risk of embolization to the lungs. It is important to detect a cause of PE, mainly in young patients to treat the underlying condition and prevent recurrences [1]. A provoked venous thromboembolism event is treated with 3–6 months of anticoagulation while a nonprovoked event is treated with a longer duration of anticoagulation [7,8].

            Case Presentation

            A healthy 22-year-old female, with no significant family history and no significant personal history presented to the emergency department for shortness of breath. She was found to have a significantly elevated DDimer level raising the suspicion of PE. A thoracic CT angiography showed bilateral proximal filling defects in pulmonary arteries confirming the diagnosis of bilateral proximal PE (Figure 1). The lower limbs venous ultrasound was negative for deep venous thrombosis. An abdominal ultrasound showed evidence of a large structure of cystic characteristics, so an abdominal magnetic resonance imaging (MRI) was ordered, and it showed an intraperitoneal extraovarian cystic structure of 11 × 28 cm which looks like a cystic lymphangioma or cystic mesothelioma compressing the inferior vena cava (IVC) (Figures 2,3). The patient underwent surgery, and the cyst was drained. Pathologic examination of the tissue showed (Figures 46). The patient was treated with Enoxaparin initially and after her surgery was switched to Rivaroxaban.

            Figure 1.

            Chest CT angiography showing filling defects in the bilateral proximal pulmonary arteries with a diagnosis of bilateral proximal PE.

            Discussion

            PE is an acute life-threatening condition that occurs when the pulmonary artery or any of its branches gets obstructed by the migration of a thrombus formed elsewhere in the body into the pulmonary circulation [9].

            Although PE can be idiopathic, it is most often associated with risk factors described as the Virchow triad consisting of stasis, vessel wall damage, and hypercoagulability. Stasis results from changes in blood flow caused by factors such as turbulence in branches and irregular vessel lumens [10]. Other conditions that cause congestion include immobilization, limb paralysis, heart failure, varicose veins, and chronic venous insufficiency [11]. Compression of the IVC by intra-abdominal masses has been described in the literature; the triggers are often malignant diseases [12], ruptured AAA [13], hepatic hemangioma [14], and desmoid tumor [15].

            Figure 2.

            Very large cystic tumor measuring 11 × 28 cm on magnetic resonance imaging of the abdomen and pelvic area.

            In our case, an intraperitoneal extraovarian cystic tumor was found to be compressing the IVC causing stasis and clot formation leading to bilateral proximal PE.

            Acute PE can present with pleuritic chest pain and dyspnea. Proper diagnosis can sometimes be challenging due to nonspecific symptoms. The diagnosis of this condition is often made through a thorough taking history of the patient’s presentation and risk factors in addition to a focused physical examination. The likelihood of having PE is then clinically assessed by Wells criteria and confirmed by the detection of emboli on imaging studies mainly computed tomography scans (CT scans). After diagnosis patients are risk stratified for further management [16].

            Figure 3.

            Very large cystic tumor measuring 11 × 28 cm on magnetic resonance imaging of the abdomen and pelvic area.

            Figure 4.

            Ovarian serous cystadenoma as seen on pathology examination post operatively.

            Figure 5.

            Ovarian serous cystadenoma as seen on pathology examination post operatively.

            Figure 6.

            Ovarian serous cystadenoma as seen on pathology examination post operatively.

            In the case of our patient, the diagnosis of bilateral proximal PE was confirmed by CT scan while the tumor causing the compression was incidentally detected on chest imaging. Further evaluation of the tumor by MRI described an intraperitoneal extra ovarian cystic formation without wall thickness or vegetation measuring 11cm × 28 cm resulting in a mass effect on the IVC. Surgery was performed during which the tumor and the left ovary were excised. The excised specimen was sent to pathology that showed ovarian serous cystadenoma.

            Serous cystadenoma is a rare adolescent ovarian tumor that arises from the surface epithelium of the ovary. Depending on the amount of fibrous tissue, it can be classified as cystadenoma, cystadenofibroma, adenofibroma, papillary cystadenoma, papillary cystadenofibroma, or papillary cystadenofibroma. Serous cystadenomas are usually oval, about 3–10 cm in diameter, with a glossy surface and clear to yellowish cystic fluid [17].

            Serous ovarian cystadenoma has previously been described in two adolescents, one presenting with abdominal distension and pain [18], and the other presenting with abdominal pain [19].

            Ovarian serous cystadenoma is a tumor that although benign in nature, could rarely lead to life-threatening effects due to its mass effect [20]. By compressing the IVC, ovarian cystadenoma could lead to thrombus formation and subsequent PE [6].

            Treatment of PE in such cases requires immediate initiation of anticoagulation therapy in addition to surgical removal of the cystadenoma to relieve its mass effect and prevent further thrombotic and embolic events [7,8]. The patient in our case was initially started on a therapeutic dose of subcutaneous enoxaparin, which was later stopped 12 hours before surgery through which she underwent cystectomy and oophorectomy, enoxaparin was later resumed for 6 months.

            Conclusion

            In short, acute PE in young female patients is unusual and should raise the suspicion for miscellaneous causes including vascular compression by tumor growths, such as ovarian serous cystadenoma. Proper evaluation and early diagnosis of these cases is crucial, as appropriate management includes surgical excision of the tumor causing the compression in addition to anticoagulant therapy, thus leading to favorable outcomes and preventing subsequent PE recurrences.

            What is new?

            PE is not a rare finding in malignant tumors but what is novel in this manuscript is that the PE originated due to the compression of the inferior vena cava by the tumor that caused venous status.

            Conflict of interest

            The authors declare that there is no conflict of interest regarding the publication of this article.

            Funding

            None.

            Consent for publication

            Written and informed consent was taken from the patients to publish this case report.

            Ethical approval

            Approval and consent of the ethics committee institutional review board were received for the publication of this article.

            References

            1. Crous-Bou M, Harrington LB, Kabrhel C. Environmental and genetic risk factors associated with venous thromboembolism. Semin Thromb Hemost. 2016. Nov;Vol. 42(8):808–20. [Cross Ref]

            2. Ali N, Ayyub M, Khan SA. High prevalence of protein C, protein S, antithrombin deficiency, and factor V Leiden mutation as a cause of hereditary thrombophilia in patients of venous thromboembolism and cerebrovascular accident. Pak J Med Sci. 2014. Vol. 30(6):1323–6. [Cross Ref]

            3. Lee JE, Kim HR, Lee SM, Yim JJ, Yoo CG, Kim YW, et al.. Clinical characteristics of pulmonary embolism with underlying malignancy. Korean J Intern Med (Korean Assoc Intern Med). 2010. Mar;Vol. 25(1):66–70. [Cross Ref]

            4. Chlapoutakis S, Georgakopoulou VE, Trakas N, Kouvelos G, Papalexis P, Damaskos C, et al.. Characteristics and outcomes of cancer patients who develop pulmonary embolism: a cross-sectional study. Oncol Lett. 2022. May;Vol. 23(5):168[Cross Ref]

            5. Ferreira F, Pereira J, Lynce A, Nunes Marques J, Martins A. Cancer screening in patients with unprovoked thromboembolism: how to do it and who benefits? Cureus. 2020. Feb;Vol. 12(2):e6934[Cross Ref]

            6. Patel SA. The inferior vena cava (IVC) syndrome as the initial manifestation of newly diagnosed gastric adenocarcinoma: a case report. J Med Case Rep. 2015. Sep;Vol. 9(1):204[Cross Ref]

            7. Couturaud F. Durée optimale du traitement anticoagulant au décours d’une embolie pulmonaire [The optimal duration of anticoagulant treatment following pulmonary embolism]. Rev Mal Respir. 2011. Dec;Vol. 28(10):1265–77. [Cross Ref]

            8. Alexander P, Visagan S, Issa R, Gorantla VR, Thomas SE. Current trends in the duration of anticoagulant therapy for venous thromboembolism: a systematic review. Cureus. 2021. Oct;Vol. 13(10):e18992[Cross Ref]

            9. Tarbox AK, Swaroop M. Pulmonary embolism. Int J Crit Illn Inj Sci. 2013. Jan;Vol. 3(1):69–72. [Cross Ref]

            10. Chung I, Lip GY. Virchow’s triad revisited: blood constituents. Pathophysiol Haemost Thromb. 2003. Sep;Vol. 33(5-6):449–54. [Cross Ref]

            11. Merli GJ. Pathophysiology of venous thrombosis, thrombophilia, and the diagnosis of deep vein thrombosis-pulmonary embolism in the elderly. Clin Geriatr Med. 2006. Feb;Vol. 22(1):75–92. [Cross Ref]

            12. Kuetting D, Thomas D, Wilhelm K, Pieper CC, Schild HH, Meyer C. Endovascular management of malignant inferior vena cava syndromes. Cardiovasc Intervent Radiol. 2017. Dec;Vol. 40(12):1873–81. [Cross Ref]

            13. Ohno A, Nishimura T, Uehara T, Shimonagata T, Kumita S, Ogawa Y, et al.. Kaku igaku. Japanese J Nucl Med. 1993. Vol. 30(5):557–61

            14. Paolillo V, Sicuro M, Nejrotti A, Rizzetto M, Casaccia M. Pulmonary embolism due to compression of the inferior vena cava by a hepatic hemangioma. Tex Heart Inst J. 1993. Vol. 20(1):66–8

            15. Palladino E, Nsenda J, Siboni R, Lechner C. A giant mesenteric desmoid tumor revealed by acute pulmonary embolism due to compression of the inferior vena cava. Am J Case Rep. 2014. Sep;Vol. 15:374–7. [Cross Ref]

            16. Toplis E, Mortimore G. The diagnosis and management of pulmonary embolism. Br J Nurs. 2020. Jan;Vol. 29(1):22–6. [Cross Ref]

            17. Abu Sulb A, Abu El Haija M, & Muthukumar A. Incidental finding of a huge ovarian serous cystadenoma in an adolescent female with menorrhagia. SAGE Open Med Case Rep. 2016. Vol. 4:2050313X16645755[Cross Ref]

            18. Mohammed Elhassan SA, Khan S, El-Makki A. Giant ovarian cyst masquerading as massive ascites in an 11-year-old. Case Rep Pediatr. 2015. Vol. 2015:878716[Cross Ref]

            19. Khalbuss WE, & Dipasquale B. Massive ovarian edema associated with ovarian serous cystadenoma: a case report and review of the literature. Int J Gynecol Cancer. 2006. Vol. 16(Suppl 1):326–30. [Cross Ref]

            20. Rashid S, Arafah MA, Akhtar M. The many faces of serous neoplasms and related lesions of the female pelvis: a review. Adv Anat Pathol. 2022. May;Vol. 29(3):154–67. [Cross Ref]

            Summary of the case

            1 Patient (gender, age) Female, 22-year-old
            2 Final diagnosis PE
            3 Symptoms Shortness of breath
            4 Medications Enoxaparin
            5 Clinical procedure Surgical removal of the cyst followed by enoxaparin
            6 Specialty Cardiology

            Author and article information

            Journal
            European Journal of Medical Case Reports
            EJMCR
            Discover STM Publishing Ltd.
            2520-4998
            30 January 2024
            : 8
            : 1
            : 9-12
            Affiliations
            [1 ]Department of Medicine, Faculty of Medicine and Medical Sciences, University of Balamand, Beirut, Lebanon
            [2 ]Department of Vascular Medicine, Faculty of Medicine, Paris Cité University, Paris, France
            [3 ]Department of Medicine, Faculty of Medicine, Sorbonne University, Paris, France
            [4 ]Department of Medicine, Faculty of Medicine and Medical Sciences, University of Balamand, Saint Georges Medical Center, Beirut, Lebanon
            [5 ]Department of Cardiology, Faculty of Medicine and Medical Sciences, University of Balamand, Beirut, Lebanon
            Author notes
            [* ] Correspondence to: Antoine El Khoury Department of Cardiology, Faculty of Medicine and Medical Sciences, University of Balamand, Beirut, Lebanon. Akhoury8@ 123456gmail.com
            Article
            ejmcr-8-9
            10.24911/ejmcr.173-1690557274
            bd43ab34-c113-4315-9eb0-a69b967892e9
            © Kristy El Morr, Edwin Sabbagh, Fadiilah Rosin, Antonios Tawk, Antoine El Khoury

            This is an open access article distributed in accordance with the Creative Commons Attribution (CC BY 4.0) license: https://creativecommons.org/licenses/by/4.0/) which permits any use, Share — copy and redistribute the material in any medium or format, Adapt — remix, transform, and build upon the material for any purpose, as long as the authors and the original source are properly cited.

            History
            : 28 July 2023
            : 30 January 2024
            Categories
            CASE REPORT

            serous ovarian cystadenoma,PE,inferior vena cava,thromboembolism,benign tumor,abdominal tumor

            Comments

            Comment on this article